7 completed, 1 withdrawn. 8 Phase 1.
By phase and status
Follow PF-06372865: new trials by email Literature Review of PF-06372865 trials Research Report on PF-06372865
Trials (filtered) newest first · largest first
All 8 trials
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|
A Trial to Assess the Absorption, Metabolism, Excretion, and Mass Balance of [14C]-Darigabat After a Single Oral Dose in Healthy Male Participants
[14C]-darigabat - Healthy Participants | Phase 1 | Completed | 8 | 2024-05-29 | 2024-07-31 |
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Repeat Doses of PF-06372865 in Healthy Subjects
Placebo, PF-06372865 - Healthy Volunteers | Phase 1 | Completed | 19 | 2017-11-08 | 2019-06-03 |
An Open-label, Two-period, Fixed-sequence Study to Evaluate Multiple-dose Itraconazole Effect on The Single-dose PK of PF-06372865 in Healthy Subjects
PF-06372865, itraconazole - Healthy | Phase 1 | Withdrawn | | 2015-07-01 | 2017-06-26 |
Assessment of the Analgesic Effects of PF-06372865 in Healthy Volunteers Using Evoked Pain Endpoints
PF-06372865 (65mg), PF-06372865 (15mg), Pregabalin - Healthy | Phase 1 | Completed | 20 | 2014-09-01 | 2014-12-16 |
Food Effect Study for PF-06372865
PF-06372865 - Healthy | Phase 1 | Completed | 12 | 2014-09-01 | 2014-10-27 |
A Study to Examine the Distribution of PF-06372865 in the Brain of Healthy Volunteers Using Positron Emission Tomography and a Radioactive Tracer Following Oral Administration of One Dose of PF-06372865
PF-06372865 - Healthy | Phase 1 | Completed | 5 | 2014-05-01 | 2014-09-25 |
A Study to Evaluate Safety, Toleration and Time Course of Plasma Concentration of Multiple Oral Doses of PF-06372865 in Healthy Subjects of Two AgeGroups, Aged 18-55 Years (Group 1) and Aged 56-75 Years (Group 2)
PF-06372865, Placebo - Healthy | Phase 1 | Completed | 50 | 2014-03-01 | 2014-08-18 |
A First In Human Study In Healthy People To Evaluate Safety, Toleration, Pharmacokinetics and Pharmacodynamics of Single Oral Doses Of PF-06372865
PF-06372865 or Placebo, PF-06372865 or Placebo or Lorazepam - Healthy | Phase 1 | Completed | 45 | 2013-10-01 | 2014-08-18 |
Conditions studied
Pain (1)
Sponsors
Pfizer (7) · Cerevel Therapeutics, LLC (1)
Countries
United States (4) · Belgium (2) · Netherlands (2)
NIH funding
2014 (2)